Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A

被引:26
|
作者
Velazquez-Moctezuma, Rodrigo [1 ,2 ,3 ]
Law, Mansun [4 ]
Bukh, Jens [1 ,2 ,3 ]
Prentoe, Jannick [1 ,2 ,3 ]
机构
[1] Univ Copenhagen, Copenhagen Hepatitis C Program CO HEP, Dept Infect Dis, Copenhagen, Denmark
[2] Univ Copenhagen, Clin Res Ctr, Hvidovre Hosp, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Immunol & Microbiol, Fac Hlth & Med Sci, Copenhagen, Denmark
[4] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
关键词
B TYPE-I; CELL-CULTURE SYSTEMS; E2; GLYCOPROTEIN; INFECTION; HCV; RECEPTOR; VACCINE; IDENTIFICATION; MUTATIONS; GENOTYPES;
D O I
10.1371/journal.ppat.1006214
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis C virus (HCV) is a major cause of end-stage liver diseases. With 3-4 million new HCV infections yearly, a vaccine is urgently needed. A better understanding of virus escape from neutralizing antibodies and their corresponding epitopes are important for this effort. However, for viral isolates with high antibody resistance, or antibodies with moderate potency, it remains challenging to induce escape mutations in vitro. Here, as proof-of-concept, we used antibody-sensitive HVR1-deleted (.HVR1) viruses to generate escape mutants for a human monoclonal antibody, AR5A, targeting a rare cross-genotype conserved epitope. By analyzing the genotype 1a envelope proteins (E1/E2) of recovered CoreNS2 recombinant H77/JFH1(Delta HVR1) and performing reverse genetic studies we found that resistance to AR5A was caused by substitution L665W, also conferring resistance to the parental H77/JFH1. The mutation did not induce viral fitness loss, but abrogated AR5A binding to HCV particles and intracellular E1/E2 complexes. Culturing J6/JFH1(Delta HVR1) (genotype 2a), for which fitness was decreased by L665W, with AR5A generated AR5A-resistant viruses with the substitutions I345V, L665S, and S680T, which we introduced into J6/JFH1 and J6/JFH1(Delta HVR1). I345V increased fitness but had no effect on AR5A resistance. L665S impaired fitness and decreased AR5A sensitivity, while S680T combined with L665S compensated for fitness loss and decreased AR5A sensitivity even further. Interestingly, S680T alone had no fitness effect but sensitized the virus to AR5A. Of note, H77/JFH1(L665S) was non-viable. The resistance mutations did not affect cell-to-cell spread or E1/E2 interactions. Finally, introducing L665W, identified in genotype 1, into genotypes 2-6 parental and HVR1-deleted variants (not available for genotype 4a) we observed diverse effects on viral fitness and a universally pronounced reduction in AR5A sensitivity. Thus, we were able to take advantage of the neutralization-sensitive HVR1-deleted viruses to rapidly generate escape viruses aiding our understanding of the divergent escape pathways used by HCV to evade AR5A.
引用
收藏
页数:29
相关论文
共 50 条
  • [21] Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1
    Mesalam, Ahmed Atef
    Desombere, Isabelle
    Farhoudi, Ali
    Van Houtte, Freya
    Verhoye, Lieven
    Ball, Jonathan
    Dubuisson, Jean
    Foung, Steven K. H.
    Patel, Arvind H.
    Persson, Mats A. A.
    Leroux-Roels, Geert
    Meuleman, Philip
    VIROLOGY, 2018, 514 : 30 - 41
  • [22] Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein
    Perotti, Mario
    Mancini, Nicasio
    Diotti, Roberta A.
    Tarr, Alexander W.
    Ball, Jonathan K.
    Owsianka, Ania
    Adair, R.
    Patel, Arvind H.
    Clementi, Massimo
    Burioni, Roberto
    JOURNAL OF VIROLOGY, 2008, 82 (02) : 1047 - 1052
  • [23] A phase 1 study evaluating the neutralizing, vaccinal monoclonal antibody VIR-3434 in participants with chronic hepatitis B virus infection
    Agarwal, Kosh
    Yuen, Man-Fung
    Wedemeyer, Heiner
    Cloutier, Daniel
    Shen, Ling
    Arizpe, Andre
    Pang, Phil
    Tay, Chin
    Gupta, Sneha V.
    Cathcart, Andrea
    Gane, Edward
    JOURNAL OF HEPATOLOGY, 2021, 75 : S288 - S288
  • [24] Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees
    Bassett, SE
    Thomas, DL
    Brasky, KM
    Lanford, RE
    JOURNAL OF VIROLOGY, 1999, 73 (02) : 1118 - 1126
  • [25] Antibody responses against B-cell epitopes of the hypervariable region 1 of hepatitis C virus in self-limiting and chronic human hepatitis C followed-up using consensus peptides
    Isaguliants, MG
    Widell, A
    Zhang, SMM
    Sidorchuk, A
    Levi, M
    Smirnov, VD
    Santantonio, T
    Diepolder, HM
    Pape, GR
    Nordenfelt, E
    JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (02) : 204 - 217
  • [26] Characterization of antibody response to hepatitis C virus protein E2 and significance of hypervariable region 1-specific antibodies in viral neutralization
    A. Zibert
    P. Dudziak
    E. Schreier
    M. Roggendorf
    Archives of Virology, 1997, 142 : 523 - 534
  • [27] Characterization of antibody response to hepatitis C virus protein E2 and significance of hypervariable region 1-specific antibodies in viral neutralization
    Zibert, A
    Dudziak, P
    Schreier, E
    Roggendorf, M
    ARCHIVES OF VIROLOGY, 1997, 142 (03) : 523 - 534
  • [28] Follow-up study of hypervariable region sequences of the hepatitis C virus (HCV) genome in an infant with delayed anti-HCV antibody responses
    Katayama, Y
    Tajiri, H
    Tada, K
    Okada, S
    Tong, WY
    Ishido, S
    Hotta, H
    MICROBIOLOGY AND IMMUNOLOGY, 1998, 42 (01) : 75 - 79
  • [29] Generation and Characterization of a Neutralizing Human Monoclonal Antibody to Hepatitis B Virus PreS1 from a Phage-Displayed Human Synthetic Fab Library
    Jo, Gyunghee
    Jeong, Mun Sik
    Wi, Jimin
    Kim, Doo Hyun
    Kim, Sangkyu
    Kim, Dain
    Yoon, Jun-Yeol
    Chae, Heesu
    Kim, Kyun-Hwan
    Hong, Hyo Jeong
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2018, 28 (08) : 1376 - 1383
  • [30] Passive immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in Hu-PBL-SCID mice: Isolation of a neutralization escape variant
    Andrus, L
    Prince, AM
    Bernal, I
    McCormack, P
    Lee, DH
    Gorny, MK
    Zolla-Pazner, S
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04): : 889 - 897